FDA Watch
Upcoming biotech catalysts — PDUFA dates, AdCom meetings, Phase 3 readouts
Binary event risk. FDA decisions are all-or-nothing. Approval: +50–200%. Rejection: -40–90%. Size accordingly.
0
Upcoming PDUFA
0
AdCom Meetings
0
Recent Approvals
0
Recent Rejections
Window:Type:Status:
Catalyst Calendar
0 events · = on watchlistLoading…